SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-027728
Filing Date
2022-10-05
Accepted
2022-10-05 17:24:24
Documents
12
Period of Report
2022-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47700
  Complete submission text file 0001493152-22-027728.txt   220777

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sigy-20221003.xsd EX-101.SCH 3254
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sigy-20221003_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sigy-20221003_pre.xml EX-101.PRE 22377
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4025
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 221296538
SIC: 3841 Surgical & Medical Instruments & Apparatus